Partner Sites
Logo

LISAbio

We empower diagnostic laboratories to grow and thrive in the evolving regulatory landscape.

Content by LISAbio

Filter by

AllArticleAudioDocumentEventInfographicSurveyVideo
Image of pegs surrounding money. Crowdfunding assays for UTIs are the initial offering from LISA in response to the FDA’s LDT final rule.
|2 min read

Initial Crowdfunding Assays Are Now Available in Response to LDT Final Rule

LISA heads up new effort with UTI assays designed to comply with the FDA’s regulations for lab-developed tests
byLISAbio
Sponsored by
Image showing coins surrounding an idea lightbulb. The Laboratory Integration Strategic Association is leading an effort to crowdsource LDT development in reaction to FDA regulations.
|3 min read

First Ever Effort to Crowdfund Diagnostic Assays Launches in Response to FDA LDT Final Rule

LISA CEO explains why crowdfunding is a viable way to shoulder the new regulatory costs behind laboratory-developed tests
byLISAbio
Sponsored by
Banner
|1 min read

Crowdfunding Solutions for CAP/COLA Labs to Overcome FDA LDT Rule Costs

Learn how clinical labs can leverage crowdfunding to reduce diagnostic test development costs and meet FDA LDT compliance requirements
byLISAbio
Sponsored by
Page 1 of 1
1

Sponsored

Thumbnail

When the Sample Waits: Pre-Analytical Variability in Multi-Analyte Blood Testing

Sponsored by
Clinical scientist working with a clinical analyzer

Protecting Clinical Lab Uptime

Sponsored by
Thumbnail

Lessons Learned from a Successful Digital Pathology Deployment at CorePath Laboratories

Sponsored by
Hero

Preserving Sample Integrity When Processing is Delayed

Sponsored by